| MRKR Stock | | | USD 1.72 0.02 1.18% |
Marker Therapeutics financial indicator trend analysis is infinitely more than just investigating Marker Therapeutics recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Marker Therapeutics is a good investment. Please check the relationship between Marker Therapeutics Total Current Assets and its Inventory accounts. Check out
Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Marker Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in industry.
To learn how to invest in Marker Stock, please use our
How to Invest in Marker Therapeutics guide.
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of
Marker Therapeutics Total Current Assets account and
Inventory. At this time, the significance of the direction appears to have significant contrarian relationship.
The correlation between Marker Therapeutics' Total Current Assets and Inventory is -0.43. Overlapping area represents the amount of variation of Total Current Assets that can explain the historical movement of Inventory in the same time period over historical financial statements of Marker Therapeutics, assuming nothing else is changed. The correlation between historical values of Marker Therapeutics' Total Current Assets and Inventory is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Total Current Assets of Marker Therapeutics are associated (or correlated) with its Inventory. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Inventory has no effect on the direction of Total Current Assets i.e., Marker Therapeutics' Total Current Assets and Inventory go up and down completely randomly.
Correlation Coefficient | -0.43 |
| Relationship Direction | Negative |
| Relationship Strength | Very Weak |
The total value of all assets that are expected to be converted into cash within one year or during the normal operating cycle.
Most indicators from Marker Therapeutics' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Marker Therapeutics current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out
Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Marker Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in industry.
To learn how to invest in Marker Stock, please use our
How to Invest in Marker Therapeutics guide.At this time, Marker Therapeutics'
Tax Provision is relatively stable compared to the past year. As of 02/18/2025,
Enterprise Value is likely to grow to about 27.1
M, while
Selling General Administrative is likely to drop slightly above 5.6
M.
When running Marker Therapeutics' price analysis, check to
measure Marker Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Marker Therapeutics is operating at the current time. Most of Marker Therapeutics' value examination focuses on studying past and present price action to
predict the probability of Marker Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Marker Therapeutics' price. Additionally, you may evaluate how the addition of Marker Therapeutics to your portfolios can decrease your overall portfolio volatility.